NO20035179D0 - Homogenisat for implantater og mikropartikler - Google Patents

Homogenisat for implantater og mikropartikler

Info

Publication number
NO20035179D0
NO20035179D0 NO20035179A NO20035179A NO20035179D0 NO 20035179 D0 NO20035179 D0 NO 20035179D0 NO 20035179 A NO20035179 A NO 20035179A NO 20035179 A NO20035179 A NO 20035179A NO 20035179 D0 NO20035179 D0 NO 20035179D0
Authority
NO
Norway
Prior art keywords
microparticles
implants
homogenize
homogenizate
homogenization
Prior art date
Application number
NO20035179A
Other languages
English (en)
Inventor
Gregor Schuetz
Birgitte Freudensprung
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26009392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20035179(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001125509 external-priority patent/DE10125509A1/de
Priority claimed from DE2002108382 external-priority patent/DE10208382A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of NO20035179D0 publication Critical patent/NO20035179D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20035179A 2001-05-23 2003-11-21 Homogenisat for implantater og mikropartikler NO20035179D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001125509 DE10125509A1 (de) 2001-05-23 2001-05-23 Lösungsmittelfreie Homogenisatherstellung
DE2002108382 DE10208382A1 (de) 2002-02-27 2002-02-27 Homogenisat für Implantate und Mikropartikel
PCT/EP2002/005680 WO2002094226A1 (de) 2001-05-23 2002-05-23 Homogenisat für implantate und mikropartikel

Publications (1)

Publication Number Publication Date
NO20035179D0 true NO20035179D0 (no) 2003-11-21

Family

ID=26009392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035179A NO20035179D0 (no) 2001-05-23 2003-11-21 Homogenisat for implantater og mikropartikler

Country Status (16)

Country Link
US (1) US8501056B2 (no)
EP (1) EP1392248B1 (no)
JP (1) JP4346909B2 (no)
AT (1) ATE369122T1 (no)
BR (1) BR0209914A (no)
CA (1) CA2449502C (no)
CY (1) CY1106944T1 (no)
CZ (1) CZ20033160A3 (no)
DE (1) DE50210646D1 (no)
DK (1) DK1392248T3 (no)
ES (1) ES2290294T3 (no)
NO (1) NO20035179D0 (no)
PL (1) PL364054A1 (no)
PT (1) PT1392248E (no)
SK (1) SK14182003A3 (no)
WO (1) WO2002094226A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1392248T3 (da) 2001-05-23 2007-11-12 Hexal Ag Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat
FR2879075B1 (fr) * 2004-12-15 2007-01-19 Adisseo France Sas Soc Par Act Procede de preparation de granules de principe actif hydrophile par extrusion
FR2879074B1 (fr) * 2004-12-15 2007-08-03 Adisseo France Sas Soc Par Act Granules de principe actif hydrophile
CN101095941B (zh) * 2006-06-29 2011-04-20 北京博恩特药业有限公司 醋酸亮丙瑞林在预防和治疗老年性骨质疏松中的新用途
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
DE102011114864A1 (de) 2011-10-05 2013-04-11 Acino Ag Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
CN104023704B (zh) * 2011-10-31 2016-08-17 花王株式会社 化妆品
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
CN107206120B (zh) * 2014-11-14 2021-06-18 南洋理工大学 生物可吸收性镁复合材料
USD782771S1 (en) 2015-04-03 2017-03-28 Geo Plastics Tight head drum
EP3492070A1 (en) 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion
USD938128S1 (en) 2020-01-06 2021-12-07 Geo Plastics Nestable drum
USD1001413S1 (en) 2020-06-30 2023-10-10 Geo Plastics Nestable drum

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992350A (en) * 1972-05-04 1976-11-16 Produits Chimiques Ugine Kuhlmann Process of mixing fillers with polytetrafluorethylene and tetrafluorethylene copolymers
US4016345A (en) 1972-12-22 1977-04-05 E. I. Du Pont De Nemours And Company Process for polymerizing tetrafluoroethylene in aqueous dispersion
FR2418067A1 (fr) 1978-02-22 1979-09-21 Omya Sa Procede pour incorporer a un polymere des additifs solides, liquides ou pateux a temperature ambiante
ES2026970T3 (es) * 1987-07-10 1992-05-16 Karl Reinhard Zeiss Procedimiento para la fabricacion y elaboracion de mezclas de sustancias sinteticas reactivas.
US4917834A (en) * 1988-11-16 1990-04-17 General Technology Applications, Inc. Method for forming homogeneous blends of particulate materials
CH679207A5 (no) * 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
US5456917A (en) 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
DE19545327C2 (de) 1995-12-05 2001-04-19 Fraunhofer Ges Forschung Verfahren zur Herstellung von hydrophobierten resorbierbaren Polyestern und deren Verwendung
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US6177609B1 (en) * 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
ZA987800B (en) * 1997-08-27 1999-06-09 Hexal Ag Pharmaceutical composition of meloxicam
US6455526B1 (en) * 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
CN1195497C (zh) 1998-12-16 2005-04-06 阿温蒂斯药物公司 生物可降解聚合物包封的5－羟色胺受体拮抗剂及其制备方法
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
DK1392248T3 (da) 2001-05-23 2007-11-12 Hexal Ag Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat
US6712850B2 (en) * 2001-11-30 2004-03-30 Ethicon, Inc. Porous tissue scaffolds for the repair and regeneration of dermal tissue
US6894088B2 (en) * 2003-03-24 2005-05-17 Baker Hughes Incorporated Process for homogenizing polyolefin drag reducing agents

Also Published As

Publication number Publication date
US20040173923A1 (en) 2004-09-09
BR0209914A (pt) 2004-04-06
WO2002094226A1 (de) 2002-11-28
PT1392248E (pt) 2007-10-11
ES2290294T3 (es) 2008-02-16
PL364054A1 (en) 2004-12-13
DE50210646D1 (de) 2007-09-20
US8501056B2 (en) 2013-08-06
JP2004530696A (ja) 2004-10-07
SK14182003A3 (sk) 2004-05-04
ATE369122T1 (de) 2007-08-15
JP4346909B2 (ja) 2009-10-21
CA2449502C (en) 2010-10-12
CZ20033160A3 (en) 2004-03-17
EP1392248A1 (de) 2004-03-03
CY1106944T1 (el) 2012-09-26
CA2449502A1 (en) 2002-11-28
DK1392248T3 (da) 2007-11-12
EP1392248B1 (de) 2007-08-08

Similar Documents

Publication Publication Date Title
CY1106944T1 (el) Μεθοδος για την παραγωγη εμφυτευματων μεσω παραγωγης - ανευ διαλυτων - ενος προϊοντος ομογενοποιησης
AU2002366083A1 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
DE60011243D1 (de) Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat
ATE539701T1 (de) Zusammengesetzte schlinge zur behandlung von inkontinenz
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
AU2002363933A1 (en) Nanogel networks including polyion polymer fragments and biological agent compositions thereof
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
MY142777A (en) Substituted indole-o-glucosides
DE60221637D1 (de) Stent mit kanälen für die haltung und verabreichung von biologisch aktivem material und methode zu seiner herstellung
UA87991C2 (en) Substituted indole-o-glucosides
DE60238058D1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
WO2007078427A3 (en) Diffusion-hardened medical implant
DE60222238D1 (de) Zusammensetzung und verfahren zur perkutanen superoxygenierung
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
WO2002096272A3 (en) Absorbable implantable vaso-occlusive member
DE60219793D1 (de) Methode zur behandlung von zytokinvermittelten erkrankungen
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE322288T1 (de) Zusammensetzungen zur immunisierung sowie deren verwendung
DE69900452D1 (de) Silikondispersion,Zusammensetzung und Verfahren zur Herstellung
DE50200244D1 (de) Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
ATE551046T1 (de) Polymere duftkapseln und ihre herstellung
ATE357469T1 (de) Sterilisierende polymere und deren herstellung und verwendung
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE60330099D1 (de) Verfahren und Anordnungen zur Herstellung, Feststellung und Übertragung von Identifikatoren
NO20034278L (no) Sammensetninger og fremgangsmåter til behandling av HCV- infeksjoner